Supplementary material S3. Genome-wide expression analysis of differentially expressed genes. 
ID	SIZE	ES	NES	NOM p-val	FDR q-val	FWER p-val	RANK AT MAX
KEGG_CHRONIC_MYELOID_LEUKEMIA	72	0.54	2.09	0	0.014	0.01	4221
KEGG_RENAL_CELL_CARCINOMA	67	0.51	2.04	0.002	0.018	0.026	4454
KEGG_GLIOMA	64	0.45	2.01	0	0.017	0.039	4221
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	107	0.5	1.97	0	0.022	0.059	4400
KEGG_AXON_GUIDANCE	129	0.51	1.96	0	0.018	0.059	4318
KEGG_ACUTE_MYELOID_LEUKEMIA	56	0.54	1.95	0.002	0.018	0.069	4221
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	125	0.42	1.95	0	0.016	0.07	6375
KEGG_PANCREATIC_CANCER	69	0.49	1.93	0.002	0.016	0.076	4221
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	128	0.54	1.91	0	0.019	0.098	4266
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	92	0.53	1.9	0.008	0.017	0.1	4221
KEGG_WNT_SIGNALING_PATHWAY	151	0.43	1.88	0.002	0.019	0.119	5893
KEGG_APOPTOSIS	86	0.48	1.88	0.002	0.018	0.121	5222
KEGG_COLORECTAL_CANCER	61	0.47	1.86	0.002	0.02	0.139	3257
KEGG_CHEMOKINE_SIGNALING_PATHWAY	183	0.55	1.86	0	0.019	0.14	4280
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	76	0.52	1.86	0.002	0.017	0.141	4349
KEGG_NON_SMALL_CELL_LUNG_CANCER	53	0.45	1.84	0	0.02	0.17	4221
KEGG_PATHWAYS_IN_CANCER	321	0.39	1.84	0	0.02	0.174	5029
KEGG_PROSTATE_CANCER	88	0.4	1.84	0.002	0.019	0.177	4221
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	210	0.44	1.82	0	0.022	0.203	5717
KEGG_NOTCH_SIGNALING_PATHWAY	47	0.59	1.79	0.02	0.027	0.246	4686
KEGG_LEISHMANIA_INFECTION	67	0.53	1.77	0.015	0.031	0.284	4642
KEGG_FOCAL_ADHESION	197	0.42	1.76	0.004	0.034	0.307	4272
KEGG_ENDOCYTOSIS	180	0.34	1.75	0.016	0.034	0.311	8309
KEGG_MELANOMA	70	0.42	1.75	0.002	0.033	0.315	4285
KEGG_GAP_JUNCTION	86	0.42	1.75	0.002	0.033	0.322	4531
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	85	0.43	1.73	0.002	0.039	0.367	4635
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	74	0.44	1.71	0.004	0.043	0.393	4221
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	114	0.41	1.7	0.002	0.048	0.429	3624
KEGG_MELANOGENESIS	100	0.42	1.69	0.002	0.049	0.445	4686
KEGG_VEGF_SIGNALING_PATHWAY	73	0.45	1.69	0.004	0.048	0.449	4349